Amentum Holdings (AMTM) Equity Average (2023 - 2026)

On a quarterly basis, Equity Average rose 2.44% to $4.7 billion in Q2 2026 year-over-year; TTM through Apr 2026 was $4.7 billion, a 2.44% increase, with the full-year FY2025 number at $4.6 billion, up 84.62% from a year prior.

Amentum Holdings (AMTM) has 4 years of Equity Average data on record, last reported at $4.7 billion in Q2 2026.

  • Equity Average reached $4.7 billion in Q2 2026 per AMTM's latest filing, up from $4.6 billion in the prior quarter.
  • Over the last five years, Equity Average for AMTM hit a ceiling of $4.7 billion in Q2 2026 and a floor of $313.5 million in Q2 2024.
  • A 4-year average of $3.1 billion and a median of $4.6 billion in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: soared 1362.2% in 2025, then grew 1.83% in 2026.
  • Tracing AMTM's Equity Average over 4 years: stood at $387.0 million in 2023, then skyrocketed by 1077.65% to $4.6 billion in 2024, then increased by 1.03% to $4.6 billion in 2025, then grew by 1.69% to $4.7 billion in 2026.
  • Business Quant data shows Equity Average for AMTM at $4.7 billion in Q2 2026, $4.6 billion in Q1 2026, and $4.6 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Relx 81.40 Bn 81.16 Bn - 3.81 Bn
2 Rentokil Initial 79.56 Bn 78.10 Bn - -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn 4.62 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn 4.89 Bn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn 1.30 Bn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn 23.69 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn 5.60 Bn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn 3.24 Bn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn 4.68 Bn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn 2.61 Bn

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 4.68 Bn
Jan 2, 2026 4.64 Bn
Oct 3, 2025 4.60 Bn
Jun 27, 2025 4.58 Bn
Mar 28, 2025 4.57 Bn
Dec 27, 2024 4.56 Bn
Sep 27, 2024 2.43 Bn
Jun 28, 2024 313.50 Mn
Mar 29, 2024 341.00 Mn
Dec 29, 2023 387.00 Mn